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Background: Posttraumatic stress disorder (PTSD) is reportedly associated with lower rates of physical activity
participation despite the known benefits of regular physical activity for improving both mental and physical health.
However, no studies have evaluated the validity or feasibility of assessing physical activity within this population
resulting in uncertainty around the reported lower rates of physical activity participation. This study aimed to
evaluate the feasibility and concurrent validity of the International Physical Activity Questionnaire-Short Form
(IPAQ-SF) and the Actigraph accelerometer (an objective physical activity monitor) among inpatients with PTSD.
Methods: Fifty-nine adult hospital inpatients with a Diagnostic Statistical Manual Mental Disorder-IV-TR diagnosis of
primary PTSD (mean age = 49.9 years; 85% male) participated in the study. Participants were asked to wear an
Actigraph accelerometer for seven consecutive days then complete the IPAQ-SF. The Spearman rho correlation
coefficient compared the amount of moderate to vigorous physical activity (MVPA) measured with the Actigraph
and the total physical activity reported in the IPAQ-SF.
Results: Lower than expected compliance with wearing accelerometers (<4 days valid data) (n = 20) was found
suggesting that the use of accelerometers within this population may not be feasible. Complete IPAQ-SF data were
available for 45 participants (76%) indicating that this tool also has its limitations in this population. The Spearman
rho was 0.46 (p = 0.01) for the 29 participants with four or more valid days of accelerometer data (as per literature
standards) and available IPAQ-SF.
Conclusion: The IPAQ-SF and the Actigraph accelerometer have limitations in people with PTSD but in those able
to provide data, show correlations of a magnitude comparable to those observed in the general population. The
development and testing of mental health specific tools may enhance measurement of physical activity in this
population.
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Post-traumatic stress disorder (PTSD) has been recently
reconceptualised in the most recent edition of the Diag-
nostic and Statistical Manual of Mental Disorders (5th edi-
tion) within a new dedicated chapter on trauma and stress
related disorders. Previously identified as an anxiety dis-
order, PTSD is categorised by symptoms of hyper-arousal,
re-experiencing and avoidance. Lifetime prevalence rates
of PTSD within the general population are estimated to be
between 5-10% [1], with occupation-specific rates among
combat veterans and police officers estimated to be as
high as 17% and 19% respectively [2,3].
Similar to other mental health conditions, people with
PTSD have higher rates of metabolic disturbances and
poor physical health compared to the general population
with higher rates of coronary heart disease, diabetes and
substance abuse [4]. People with PTSD are less likely to
engage in regular physical activity compared with the
general population and are also more likely to be nico-
tine dependent [5,6].
Regular physical activity, or structured exercise, has
been shown to have anti-depressant and anxiolytic qual-
ities [7,8], although no randomised controlled trials have
evaluated the effects of structured physical activity on
symptoms of PTSD [9,10]. Preliminary reports suggest
that increasing physical activity within PTSD treatment
programs may be beneficial for improving outcomes [9]
whilst simultaneously reducing the incidence of meta-
bolic syndrome and cardiovascular disease [11,12].
As physical activity programs become routinely incorpo-
rated into PTSD treatment facilities, it is vital that clini-
cians have reliable and valid measures of physical activity
that are also feasible to collect. Common methods of
physical activity assessment include self-report question-
naires and objective monitors such as accelerometers. The
International Physical Activity Questionnaire- Short Form
(IPAQ-SF) is a frequently used four question, self-report
measure of physical activity participation during the previ-
ous seven-day period [13]. A 2011 systematic review of
validation studies reporting the correlation between total
physical activity, as measured by an accelerometer, and the
IPAQ-SF within both clinical and general populations
found r values ranging from 0.09 to 0.39, with a tendency
for the IPAQ-SF to over-estimate physical activity [14].
Despite this relatively low correlation with an objective
measure, the IPAQ-SF is quick to administer, can be self-
completed, and has previously been used with other psy-
chiatric populations [15,16]. No specific validity evidence
exists for the IPAQ-SF for use among people with PTSD,
and no studies to date have utilised accelerometers within
this clinical population. Given the relatively higher rates of
occupation-related PTSD found in physically demanding
roles such as police and military service compared to
sedentary occupations, it is reasonable to question andtherefore test the validity of a self-report questionnaire
within this specific population. Furthermore accelerome-
ters have been previously used in the assessment of pa-
tients with mental illness, with compliance to wearing the
monitors reported as low as 45% in one sample of 55 par-
ticipants with varying psychiatric diagnoses [17]. As such
we also felt it was necessary to test the feasibility of using
accelerometers in patients with PTSD.
The aim of this study was to a) evaluate the feasibility
of the International Physical Activity Questionnaire-Short
Form (IPAQ-SF) and the Actigraph accelerometer among
inpatients with posttraumatic stress disorder (PTSD) and b)
determine the concurrent validity of these two instruments.
Methods
Sample and procedures
Fifty-nine adult participants were recruited from the in-
patient trauma program at St John of God Health Care,
Richmond Hospital (Australia) between May 2011 and
April 2012. All participants met DSM-IV diagnostic cri-
teria for PTSD, were ambulatory and cognitively able to
provide consent. Potential participants were excluded if
they were pregnant or medically restricted from partici-
pating in physical activity due to significant physical in-
jury or illness. Ethical approval was obtained for this
study from St John of God Health Care’s Ethical Com-
mittee (REF: 412) and The University of Sydney Human
Research Ethics Committee (Protocol No 14091). Writ-
ten informed consent was obtained from all participants.
Demographic information including age, sex and gen-
eral medical and psychiatric history was collected by
means of a questionnaire. The Health of Our Nation
Outcome Scale (HoNOS) [18] was used to assess illness
severity with the aim of determining what effect, if any,
the severity of symptoms had on the correlation between
the accelerometer and IPAQ-SF. The HoNOS is a stan-
dardised assessment tool used throughout mental health
settings [18], and although not specific to PTSD, the
HoNOS consists of 12 general items, each scored from
0–4 resulting in total scores of between 0 and 48, with
higher scores indicating a greater illness severity.
The Actigraph GT3X accelerometer (Actigraph LLC,
Pensacola, FL, US) is a small electronic device the size
of a small beeper worn by individuals to record levels of
physical activity and sedentary behaviour. Participants
were provided with an Actigraph GT3X accelerometer
as well as written wearing instructions, and were asked
to wear the accelerometer on the right hip for all waking
hours during a 7-day period, except during water-based
activities. Participants were instructed to wear the accel-
erometer if napping during daytime hours. The Acti-
graph output includes movement counts/ minute for the
vertical, anterior-posterior, and mediolateral axes. The
epoch was set at 1-second intervals. Accelerometer cut-
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light activity (100–1951 counts/minute), moderate activ-
ity (1952–5724 counts/minute) and vigorous activity
(>5725 counts/minute) [19,20]. In order to maximise ac-
celerometer wear time, nursing staff prompted partici-
pants at regular intervals throughout the day (during
required nursing rounds) to wear the monitors, and a re-
minder notice was posted on the unit whiteboard.
Following the 7-day period, participants completed the
IPAQ-SF. The IPAQ-SF assesses four domains of physical
activity over the previous week, including vigorous activity
(activities that make breathing much harder than normal),
moderate activity (activities that make breathing some-
what harder than normal), walking and time spent sitting.
Data from the IPAQ-SF were scored as per the IPAQ-SF
scoring manual [13]. As recommended by the manual,
questionnaires were excluded from the analysis if they
contained erroneously high values (cases in which the sum
total of all walking, moderate and vigorous time variables
is greater than 960 minutes). Total physical activity (mi-
nutes per week), was calculated by combining the totals
for the walking, moderate and vigorous categories.
Statistical analyses
Participants were included in the statistical analyses if
they recorded at least three valid days of accelerometerTable 1 Participant demographic information
Total (n = 59)
Male gender, n(%) 50 (85%)
Age, mean (SD) 49 (12)
Body Mass Index (n = 46)
18.5-24 (healthy) 4 (9%)
25-29 (overweight) 22 (48%)
30-39 (obese) 20 (43%)






Police officer 29 (51%)
Defense 15 (26%)
Motor vehicle accident 13 (23%)
Lower illness severity (HoNOS <21)# 23 (41%)
Higher illness severity (HoNOS > =21)# 33 (59%)
Years since diagnosis, mean (SD) 2.7 (4.3)
Current smoker 16 (27%)
Benzodiazepam use (sedative) 19 (32%)
*Excluded from analysis due to < 3 days of valid accelerometer data or missing IPAQ
#n = 56 due to missing data.data. Analyses were conducted with both at least three,
and at least four valid days. A valid day was defined as at
least 10 hours of wear time, and periods of 60-minutes or
more of consecutive zeros were considered as non-wear
time. All analyses were performed with SPSS statistical
software. The concurrent validity of the IPAQ-SF against
the accelerometer was determined using Spearman rho
correlation coefficients, calculated for both minutes per
day of moderate to vigorous physical activity, and total sit-
ting (IPAQ-SF) and sedentary time (accelerometer) per
weekday. Bland-Altman plots with 95% limits of agree-
ment were calculated as the measures of agreement be-
tween the instruments. The median HoNOS score (21)
was used as the dichotomisation point to stratify partici-
pants according to illness severity, and t-tests were used to
determine the impact of illness severity on accelerometer-
recorded physical activity.
Results
Anthropomorphic, demographic and diagnostic partici-
pant data are included in Table 1. The mean age of partici-
pants was 49.9 years (SD = 11.9, range = 23–71 years).
Mean Body Mass Index (BMI; height2 (m)/ weight (kg))
was 30.2 (SD = 4.6), with 9% of participants being normal
weight, 48% overweight, and 44% obese (class I or II obes-
ity) [21] (mean weight = 94.4 kg (SD = 16.2)). PreviousExcluded* (n = 10) Included (n = 49)
7 (70%) 43 (88%)
48 (12) 51 (12)
1 (16%) 3 (8%)
2 (34%) 20 (50%)
3 (50%) 17 (42%)
7 (70%) 32 (65%)
0 12 (23%)
2 (20%) 1 (3%)
1 (10%) 4 (9%)
7 (70%) 22 (46%)
3 (30%) 14 (28%)
0 13 (26%)
3 (30%) 21 (45%)
7 (70%) 26 (55%)
1.7 (2.5) 2.9 (4.6)
5 (50%) 11 (22%)
4 (40%) 15 (31%)
-SF.
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participants having no previous psychiatric admissions (n =
39, 66%). Current or past serving police duties were cited
as the leading cause of trauma (n = 29, 49%), with the next
largest contributor being defence personnel duties (n = 15,
25%), followed by motor-vehicle accidents (n = 4, 7%). Nine
participants cited other causes such as assault, sexual as-
sault and non-specified traumatic experiences. The cause of
experienced trauma was mostly employment-related (85%)
with a mean time to diagnosis from the traumatic event
2.7 years (SD = 4.3). The mean total HoNOS illness severity
score was 19.9 (SD = 6.5).
In total ten of the 59 participants (17%) recorded zero,
one or two valid days of accelerometer data, whilst only
eight (14%) recorded the full seven valid days. A further
ten participants (17%) recorded three valid days, five
(15%) recorded four valid days, nine (15%) recorded five
valid days and 17 (29%) recorded six valid days. Litera-
ture standard is to only include participants with at least
four valid days of data, but given the poor compliance
we performed sensitivity analyses for both 3+ and 4+
valid days, which showed similar results (Table 2).
In total seven of 59 (12%) IPAQ-SFs were incomplete
due to sudden or early discharge and eight of 59 (14%)
reported values that were considered erroneously high
(physical activity ≥16 hours per day) and were excluded
from the analysis as advised in the IPAQ-SF scoring
manual. Illness severity was not found to significantly
impact compliance with either the accelerometer or the
IPAQ-SF.
As shown in Table 2, the Spearman rho correlation be-
tween moderate and vigorous physical activity based on
the accelerometer and total physical activity from the
IPAQ-SF was 0.46 (95% confidence interval (95% CI) =
0.11 to 0.71, ≥four valid days) and 0.45 (95% CI = 0.15 to
0.68, ≥three valid days). The Spearman correlation be-
tween sitting time per weekday based on the IPAQ-SF
and sedentary time per day as assessed with the acceler-
ometer was 0.29 (95% CI = 0.15 to 0.68, ≥four valid days)




3+ valid days 49 Mean (SD)
Median (25th% - 75th%)
4+ valid days 39 Mean (SD)
Median (25th% - 75th%)
Sedentary time (mins/weekday)
3+ valid days 38 Mean (SD) Median (25th% - 75th%)
4+ valid days 29 Mean (SD) Median (25th% - 75th%)For participants with a greater illness severity as de-
fined by a HoNOS score of ≥21, the Spearman correl-
ation for physical activity between the accelerometer and
the IPAQ-SF was 0.46 (95%CI = 0.02 to 0.75, ≥three valid
days; n = 20) and 0.59 (95%CI = 0.09 to 0.85, ≥four valid
days; n = 14).
For those with a lesser illness severity the correlation
was 0.46 (95%CI = −0.05 to 0.78) (≥three valid days; n =
16) and 0.48 (95%CI = −0.07 to 0.81, ≥four valid days; n =
14) (Table 3).
The Spearman correlation between sitting time based on
the IPAQ-SF and accelerometer for those with a greater ill-
ness severity was −0.001 (95%CI = −0.41 to 0.41, ≥three
valid days; n = 23) and 0.33 (95%CI = −0.16 to 0.69, ≥four
valid days; n = 18). For participants with a lesser illness
severity the correlation was 0.28 (95% CI = −0.19 to
0.64, ≥three valid days; n = 20) and 0.34 (95% CI = −0.17 to
0.71), ≥four valid days; n = 17).
The Bland-Altman plot for moderate-vigorous physical
activity (Figure 1) indicates that the IPAQ-SF has poor
agreement with the accelerometer, particularly as phys-
ical activity volume increases which is comparable to
other studies investigating the relationship between ac-
celerometers and the IPAQ [22]. The plot for sedentary
time (Figure 2) shows poor agreement between the ac-
celerometer and IPAQ-SF that worsens as mean seden-
tary time increases.
Discussion and conclusions
This study found poorer than expected compliance with
both measures of physical activity but found that, among
those who provided data for both tools, the IPAQ-SF
and Actigraph have similar correlations compared to the
general population [22].
The high number of participants excluded from the final
analysis due to invalid accelerometer data or erroneous
IPAQ-SF questionnaire responses is an important finding.
Contributing factors to poor accelerometer compliance
may include a lack of motivation and fatigue, the location
of the objective monitoring device (hip, wrist, ankle,celerometer and the International Physical Activity
N IPAQ-SF (mins/day) Spearman’s rho
correlation
40 (31) 37 43 (38) 0.45
35 (20–54) 30 (11–69)
42 (31) 29 45 (38) 0.46
36 (22–54) 30 (16–69)
444 (393–550) 474 (119) 34 600 (360–840) 611 (321) 0.33
481 (110) 440 (410–536) 27 598 (321) 540 (360–840) 0.29
Table 3 Accelerometer assessed physical activity data stratified by illness severity; mean (SD)
Lesser illness severity (HoNOS ≥21) (n = 21) Greater illness severity (HoNOS <21) (n = 26) P-value (t-test)
Counts/ day 303697 (194674) 259940 (112820) 0.12 ns
Steps/ day 8563 (3996) 8562 (3237) 0.63 ns
Light activity (mins/day) 197 (42) 214 (48) 0.56 ns
Moderate activity (mins/day) 42 (28) 35 (25) 0.72 ns
Vigorous activity (mins/day) 5 (16) 2 (3) 0.05 ns
Wear time (mins/day) 784 (89) 809 (96) 0.5 ns
Sedentary time (mins/day) 540 (75) 559 (83) 0.65 ns
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the monitors. Future studies utilising accelerometer mea-
surements within inpatient PTSD populations may benefit
from a multi-disciplinary approach to increasing com-
pliance by utilising health professionals in contact with
patients on a regular basis, such as nursing staff, psycholo-
gists and occupational therapists.
Of the 52 completed IPAQ-SF questionnaires, eight
were excluded from the analysis due to erroneously high
values. Future research with psychiatric inpatients may
also benefit from using an interview to administer the
IPAQ-SF to improve the accuracy of physical activity
reporting. Nursing and allied health staff in regular contact
with inpatients would be appropriately placed to adminis-
ter such an interview. Given that 74% of participants in
this study were from a police or defence background, it is
possible that participants may have reported physical ac-
tivity based on their pre-trauma levels of participation, in
which physical activity and regular exercise would have
been required for occupational purposes. Over reportingFigure 1 Bland-Altman plot of agreement between accelerometer andhas previously been acknowledged as a key limitation of
self-reported measures of physical activity [14].
Among those who provided data for both tools, the cor-
relation between the IPAQ-SF and Actigraph was reason-
ably high (0.46) indicating acceptable concurrent validity
for estimating the physical activity of inpatients with PTSD
based on findings from similar studies in other populations
[22]. This degree of correlation is comparable with that in
the general population where values of up to 0.39 have
been identified [14]. The missing data indicate that this
value may not be transferrable to the general inpatient
population with PTSD and suggest that the development
of a tool specifically designed for people with mental
health problems may be warranted.
Illness severity was not strongly associated with phys-
ical activity levels, or compliance with either the acceler-
ometer or IPAQ-SF. Illness severity however did impact
upon the strength of the relationship between time spent
in sedentary behaviour and sitting time as per the IPAQ-
SF. This has implications for practice, and highlights aself-reported moderate vigorous physical activity time.
Figure 2 Bland-Altman plot of agreement between accelerometer and self-reported sedentary time.
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psychiatric facilities, especially for those with a greater
illness severity.
The high rate of excluded data is a significant limita-
tion of this study, and serves to highlight the pragmatic
limitations associated with assessing physical activity in
PTSD. The relatively small number of female partici-
pants is another potential limitation, as differences in
feasibility and compliance to either measure may exist
between sexes that were unable to be assessed within
this study. The IPAQ-SF asks participants about physical
activity participation in bouts of at least ten-minutes
only. This was not accounted for in the analysis of the
accelerometer data, which we acknowledge as a potential
limitation of this study.
Both the IPAQ-SF and accelerometers have limitations
when used with inpatients with PTSD, including over-
reporting and poor compliance to wearing objective
monitors. The quick administration time and moderate
correlation with an objective measure of physical activity
are strengths of the IPAQ-SF, however further research
is needed to identify optimal approaches to measure-
ment of physical activity in people with mental health
problems [16]. The development and testing of mental
health specific tools may enhance measurement of phys-
ical activity in this population.
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